España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Juan Spínelli
Breaking Taboos: Rabbi Leads Research On Psychedelics And Jewish Identity
A new study explores Jewish Americans' relationship with psychedelics, aiming to understand their spiritual and cultural significance within the community.
Sexual Health: Psychedelics Found To Enhance Function In Imperial College Study
A new study shows psilocybin may improve sexual function for months, offering potential benefits for sexual health and depression.
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
DEA's cannabis rescheduling hearing begins January 21, 2025, as the industry raises concerns over process transparency and political influence.
Portland Launches Nation's First Psilocybin Service Center Combining Mindfulness Practices
Portland's PNW Integrative Center combines psilocybin therapy with mindfulness practices to provide transformative experiences for mental health and wellness.
Mapping How Ayahuasca Affects Fear Circuits: Key Insights From New Research
New research explores how ayahuasca influences brain circuits involved in fear and anxiety, offering insights into its potential therapeutic uses
Aaron Rodgers Opens Up About Psychedelic Healing In New Netflix Docuseries, 'Enigma'
Aaron Rodgers explores his healing journey in Enigma, offering a deep dive into his emotional and spiritual recovery. Premieres Dec. 17.
Psilocybin Mushroom Debate Heats Up In Detroit As The City Raids Healing Shack
Detroit's Psychedelic Healing Shack faces closure after a city raid over psilocybin mushrooms. Owner claims religious freedom to sell them.
TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir
Kendis Gibson's new memoir Five Trips details his journey through mental health struggles, childhood trauma, and psychedelic healing.
VA Funds $1.5M MDMA Study To Treat PTSD In Veterans
The VA announces a $1.5 million study on MDMA-assisted therapy for veterans with PTSD and AUD, advancing psychedelic research.
RFK Jr.'s Anti-Science Views 'Could Be Very Dangerous' For Psychedelics Movement Says Michael Pollan
Pollan shares concerns about RFK Jr.'s stance on psychedelics, warning that his anti-science views could undermine the movement's credibility.
Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential
Kelly Slater explores the transformative potential of psychedelics for mental health and unlocking human performance.
Veterans Seek Healing Through Psychedelic Therapy As Seen In New Documentary 'In Waves And War'
In Waves and War showcases the transformative power of psychedelic therapy for veterans battling PTSD and TBI.
Silicon Valley Titans And Their Psychedelic Journeys: The Experiences That Shaped Them
Silicon Valley's top leaders, including Steve Jobs, Sam Altman, and Elon Musk, share their experiences with psychedelics, from personal transformation to innovation.
Yale Center Invests $600K+ On Cannabis Research Grants: These Are The Key Conditions Being Studied
Yale's Center announces $600K in grants to 14 researchers studying cannabis' impact on brain development and mental health.
Brazil Greenlights Hemp Production, Sale: A Game-Changer For Medical Cannabis
Brazil's recent court ruling on industrial hemp cultivation for medical use signals a major shift in the country's cannabis landscape.
Gold Flora Faces Receivership Proceedings As Financial Struggles Deepen
California-based cannabis operator Gold Flora faces receivership amid $37M losses and unpaid debts, while pursuing bold expansion plans.
DEA Sets Stage For Marijuana Rescheduling With December 2 Hearing
DEA to host a procedural hearing on marijuana rescheduling December 2, addressing tax relief, research barriers, and political tensions.
Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia
Virginia lawmakers fail to advance legislation to explore psychedelic therapies like psilocybin, leaving future treatment uncertain.
DMT: The Hidden 'Spirit Molecule' Within Your Body
DMT, known as the "spirit molecule," could be key to understanding dreams, near-death experiences, and spiritual awakenings.
COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What's Next For This Psychedelics Co?
COMPASS Pathways faces $43M market cap loss, raising concerns among institutional investors holding 30% ownership.